Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Genedrive PLC (GB:GDR)
LSE:GDR
Genedrive (GDR) Share Price & Analysis
9 Followers
GDR Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range2.56p - 25.90p
Previous Close5.88p
Volume744.96K
Average Volume (3M)3.13M
Market Cap
£8.41M
Enterprise Value6.05M
Total Cash (Recent Filing)£2.60M
Total Debt (Recent Filing)£241.00K
Price to Earnings (P/E)-1.3
Beta-0.54
Next Earnings
Nov 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding115,139,946
10 Day Avg. Volume3,811,542
30 Day Avg. Volume3,129,982
Standard Deviation0.52
R-Squared0.02
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)3.32
Price to Sales (P/S)196784.64
Price to Cash Flow (P/CF)-2.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Genedrive News
PremiumCompany Announcements
Genedrive Advances FDA Approval for Hearing Loss TestOptions Prices
Currently, No data available
---
Ownership Overview
2.43%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
97.57% Public Companies and
Individual Investors
GDR FAQ
What was Genedrive PLC’s price range in the past 12 months?
Genedrive PLC lowest share price was 2.56p and its highest was 25.90p in the past 12 months.
What is Genedrive PLC’s market cap?
Currently, no data Available
When is Genedrive PLC’s upcoming earnings report date?
Genedrive PLC’s upcoming earnings report date is Nov 19, 2024 which is in 207 days.
How were Genedrive PLC’s earnings last quarter?
Genedrive PLC released its earnings results on Mar 28, 2024. The company reported -0.02p earnings per share for the quarter, missing the consensus estimate of N/A by -0.02p.
Is Genedrive PLC overvalued?
According to Wall Street analysts Genedrive PLC’s price is currently Overvalued.
Does Genedrive PLC pay dividends?
Genedrive PLC does not currently pay dividends.
What is Genedrive PLC’s EPS estimate?
Genedrive PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genedrive PLC have?
Genedrive PLC has 143,141,480 shares outstanding.
What happened to Genedrive PLC’s price movement after its last earnings report?
Genedrive PLC reported an EPS of -0.02p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4%.
Which hedge fund is a major shareholder of Genedrive PLC?
Currently, no hedge funds are holding shares in GB:GDR
---
Genedrive Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.45%
12-Months-Change
Fundamentals
Return on Equity
-201.53%
Trailing 12-Months
Asset Growth
-28.84%
Trailing 12-Months
Company Description
Genedrive PLC
Genedrive PLC is a holding company engaged in molecular diagnostics business. It operates in one operating segment named as Diagnostics which is engaged in Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Geographically the majority of the revenue is derived from the United States of America.
---
Technical Analysis
Omega Diagnostics
―
Allergy Therapeutics
―
RUA Life Sciences
―
EKF Diagnostics Holdings
―
---